DE69428268T2 - Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma - Google Patents
Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthmaInfo
- Publication number
- DE69428268T2 DE69428268T2 DE69428268T DE69428268T DE69428268T2 DE 69428268 T2 DE69428268 T2 DE 69428268T2 DE 69428268 T DE69428268 T DE 69428268T DE 69428268 T DE69428268 T DE 69428268T DE 69428268 T2 DE69428268 T2 DE 69428268T2
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- bronchial
- localane
- aesthma
- aesthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/012,343 US5510339A (en) | 1993-02-02 | 1993-02-02 | Method for the treatment of bronchial asthma by administration of topical anesthetics |
PCT/US1994/000901 WO1994017790A1 (en) | 1993-02-02 | 1994-01-25 | Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69428268D1 DE69428268D1 (de) | 2001-10-18 |
DE69428268T2 true DE69428268T2 (de) | 2002-06-27 |
Family
ID=21754520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69428268T Expired - Lifetime DE69428268T2 (de) | 1993-02-02 | 1994-01-25 | Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma |
Country Status (12)
Country | Link |
---|---|
US (2) | US5510339A (de) |
EP (1) | EP0682514B1 (de) |
JP (2) | JPH08505157A (de) |
AT (1) | ATE205389T1 (de) |
AU (1) | AU685777B2 (de) |
CA (1) | CA2155200C (de) |
DE (1) | DE69428268T2 (de) |
DK (1) | DK0682514T3 (de) |
ES (1) | ES2164097T3 (de) |
NZ (1) | NZ261990A (de) |
PT (1) | PT682514E (de) |
WO (1) | WO1994017790A1 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
US20020032160A1 (en) * | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
US5928883A (en) * | 1996-11-13 | 1999-07-27 | Mayo Foundation For Medical Education | Eosinophil granole proteins as indicators of inflammatory bowel disorders |
US6071910A (en) * | 1996-12-05 | 2000-06-06 | Mayo Foundation For Medical Education And Research | Use of agents to treat eosinophil-associated pathologies |
US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
US5881720A (en) * | 1997-04-29 | 1999-03-16 | The Procter & Gamble Company | Method of delivering halotherapy |
AU9294698A (en) * | 1997-08-27 | 1999-03-16 | Beth Israel Deaconess Hospital Corp. | Methods and compositions for enhanced wound healing |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
WO1999049865A1 (en) * | 1998-03-31 | 1999-10-07 | Mayo Foundation For Medical Education And Research | Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation |
US6172053B1 (en) | 1999-02-24 | 2001-01-09 | Ruben G. Fabunan | Injection viral treatment |
US6576224B1 (en) | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
WO2001028550A1 (en) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
JP2003512321A (ja) * | 1999-10-15 | 2003-04-02 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | PKC−δ活性のモジュレーションによる好酸球関連疾病の治療 |
CA2292902C (en) * | 1999-12-24 | 2012-12-18 | Alain Cadieux | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
US20020046357A1 (en) * | 1999-12-28 | 2002-04-18 | Jiandong Huang | Software-based fault tolerant networking using a single LAN |
US6846486B1 (en) * | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
AU7138601A (en) * | 2000-06-23 | 2002-01-08 | Mayo Foundation | Methods of treating neutrophil-related diseases with topical anesthetics |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
CA2445086C (en) | 2001-05-01 | 2008-04-08 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US20050215727A1 (en) * | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
ES2587187T3 (es) * | 2001-05-01 | 2016-10-21 | A. V. Topchiev Institute Of Petrochemical Synthesis | Composición bioadhesiva absorbente de agua bifásica |
CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
WO2004048519A2 (en) * | 2002-11-21 | 2004-06-10 | Ira Sanders | Treatment of mammalian reaction to ige interactions |
US20050119340A1 (en) * | 2003-06-13 | 2005-06-02 | David Anderson | Treatment methods with low-dose, longer-acting formulations of local anesthetics and other agents |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
EP1729724A4 (de) | 2003-12-31 | 2008-07-23 | Cydex Inc | Inhalationsformulierung mit sulfoalkylether-gamma-cyclodextrin und corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
WO2005074894A1 (en) | 2004-01-30 | 2005-08-18 | Corium International | Rapidly dissolving film for delivery of an active agent |
EP1730751B1 (de) * | 2004-03-12 | 2009-10-21 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Magnetoresistives medium |
WO2005102313A1 (ja) * | 2004-04-21 | 2005-11-03 | Kyowa Hakko Kogyo Co., Ltd. | 慢性副鼻腔炎の予防および/または治療剤 |
CN103497713B (zh) * | 2004-08-05 | 2018-07-17 | 考里安国际公司 | 粘合剂组合物 |
AU2005316687B2 (en) * | 2004-12-16 | 2008-06-26 | Alkermes, Inc. | Compositions and methods for pulmonary conditions |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
CA2642641A1 (en) * | 2006-02-15 | 2007-08-23 | Tika Laekemedel Ab | Stable corticosteroid mixtures |
WO2007136707A2 (en) * | 2006-05-17 | 2007-11-29 | University Of Utah Research Foundation | Methods and compositions related to eosinophil regulation |
US20100260744A1 (en) * | 2007-07-11 | 2010-10-14 | Medvet Science Pty Ltd. | Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
AU2010204986B2 (en) | 2009-01-14 | 2016-06-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
RU2446839C1 (ru) * | 2010-08-13 | 2012-04-10 | Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (ГУ МОНИКИ им. М.Ф. Владимирского) | Способ комплексного лечения больных с воспалительными заболеваниями придаточных пазух носа |
US9636425B2 (en) * | 2012-09-18 | 2017-05-02 | Focal Point Technologies, Llc | Method of dry dye delivery for staining the eye |
WO2016205172A1 (en) * | 2015-06-15 | 2016-12-22 | Banner Life Sciences Llc | Soft lozenges comprising corticosteroids |
US9867834B2 (en) * | 2015-06-15 | 2018-01-16 | Banner Life Sciences Llc | Non-systemic topical compositions comprising corticosteroids |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3385M (fr) * | 1963-12-02 | 1965-06-21 | Sobio Lab | Compositions thérapeutiques a base d'ascorbate de procaine. |
US4626530A (en) * | 1981-06-23 | 1986-12-02 | Schulte Thomas L | Treatment of eye inflammation with biphenamine |
US4466973A (en) * | 1983-02-01 | 1984-08-21 | Thomas Rennie | Method of treating nasal and sinus congestion |
US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
US5134166A (en) * | 1988-12-02 | 1992-07-28 | Genderm Corporation | Method for treating nasal disorders and headaches |
-
1993
- 1993-02-02 US US08/012,343 patent/US5510339A/en not_active Expired - Lifetime
-
1994
- 1994-01-25 NZ NZ261990A patent/NZ261990A/xx unknown
- 1994-01-25 AU AU61282/94A patent/AU685777B2/en not_active Ceased
- 1994-01-25 PT PT94907887T patent/PT682514E/pt unknown
- 1994-01-25 AT AT94907887T patent/ATE205389T1/de not_active IP Right Cessation
- 1994-01-25 JP JP6518086A patent/JPH08505157A/ja active Pending
- 1994-01-25 CA CA002155200A patent/CA2155200C/en not_active Expired - Fee Related
- 1994-01-25 EP EP94907887A patent/EP0682514B1/de not_active Expired - Lifetime
- 1994-01-25 DE DE69428268T patent/DE69428268T2/de not_active Expired - Lifetime
- 1994-01-25 WO PCT/US1994/000901 patent/WO1994017790A1/en active IP Right Grant
- 1994-01-25 DK DK94907887T patent/DK0682514T3/da active
- 1994-01-25 ES ES94907887T patent/ES2164097T3/es not_active Expired - Lifetime
-
1996
- 1996-03-20 US US08/618,860 patent/US5631267A/en not_active Expired - Lifetime
-
2001
- 2001-01-25 JP JP2001017379A patent/JP2001192334A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2155200C (en) | 2006-12-19 |
JP2001192334A (ja) | 2001-07-17 |
EP0682514B1 (de) | 2001-09-12 |
AU685777B2 (en) | 1998-01-29 |
DK0682514T3 (da) | 2002-01-14 |
EP0682514A1 (de) | 1995-11-22 |
PT682514E (pt) | 2002-03-28 |
JPH08505157A (ja) | 1996-06-04 |
WO1994017790A1 (en) | 1994-08-18 |
DE69428268D1 (de) | 2001-10-18 |
ATE205389T1 (de) | 2001-09-15 |
CA2155200A1 (en) | 1994-08-18 |
ES2164097T3 (es) | 2002-02-16 |
AU6128294A (en) | 1994-08-29 |
US5631267A (en) | 1997-05-20 |
US5510339A (en) | 1996-04-23 |
NZ261990A (en) | 1997-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69428268T2 (de) | Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma | |
DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
DE69418601D1 (de) | Guanidinderivate mit therapeutischer wirkung | |
ES538807A0 (es) | Un procedimiento para la produccion de un complejo covalentemente unido de inhibidor de alfa-1-proteinasas con un polimero soluble en agua. | |
ATE230985T1 (de) | Verwendung von xanthophyllen zur herstellung von arzneimitteln zur verbesserung der muskel- funktionsdauer oder zur behandlung von muskelstörungen oder erkrankungen | |
DE69428523D1 (de) | Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind | |
DE69903750T2 (de) | Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten | |
ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
DE69029100D1 (de) | Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
DE68912195T2 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
ATE192646T1 (de) | Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren | |
ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
ATE289816T1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
DE59409394D1 (de) | Therapeutisches system zur behandlung der psoriasis | |
DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
MXPA02009603A (es) | Terapias de dosis divididas con actividad de deterioro vascular. | |
DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
DE69428797T2 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
RU2003118131A (ru) | Способ лечения ран | |
ATE234620T1 (de) | Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis | |
DE69909970D1 (de) | Verwendung von 2-amino-6-trifluoromethoxybenzothiazol zur herstellung eines arzneimittels zur vorbeugung oder behandlung von zerebellumkrankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803 |